Latest Safety News

Resources & Energy Group Limited (REZ) reports strong progress in gold production at East Menzies with two successful gold pours and a $1.1 million capital raise, while divesting its Mount Mackenzie asset to sharpen focus on Western Australia.

Tryptamine Therapeutics has initiated the first-ever clinical trial using IV-infused psilocin to treat Binge Eating Disorder, with patient dosing set to begin shortly and results expected by year-end.

Vectus Biosystems confirms safety of its lead fibrosis drug VB0004 from Phase Ia/Ib trials and advances licensing talks globally, including in China, while managing costs and funding challenges.

DGR Global Limited reports steady progress in project generation and subsidiary investments, bolstered by a $23.5 million loan facility and a favorable legal appeal outcome. The company maintains a strong health, safety, and environmental record while navigating challenging market conditions.

RBR Group Limited is strategically positioning itself to capitalise on the restart of major LNG projects in Mozambique, advancing joint ventures and raising capital to meet anticipated demand.

Constellation Technologies broadens its Callisto Food Safety platform into new sectors and launches innovative IoT products, while managing a modest cash outflow in Q4 2025.

Hastings Technology Metals has formalized a 60 – 40 unincorporated joint venture with Wyloo for the Yangibana Rare Earths and Niobium Project, significantly reducing capital costs and advancing development. The company also moves to diversify with a conditional acquisition of the Whiteheads Gold Project and appoints Vince Catania as CEO.

Australian Pacific Coal Limited has entered receivership over its Dartbrook Joint Venture assets following a senior secured debt default, casting doubt on the value of its 80% stake. Despite holding cash reserves, the company assumes no value in the joint venture amid ongoing financial distress.

Clarity Pharmaceuticals has bolstered its cash reserves to approximately $288 million following a $203 million institutional placement, while reporting significant clinical progress across multiple copper-based radiopharmaceutical trials targeting prostate cancer and neuroendocrine tumours.

EQ Resources delivered a robust Q4 FY2025 with strong tungsten output from its Spanish and Australian operations, bolstered by strategic capital raises and key plant enhancements.

Pilot Energy has secured a $1.5 million debt note to bolster cash flow ahead of a substantial $4.5 million Petroleum Resource Rent Tax refund linked to the decommissioning of the Cliff Head Oil Field.

Northern Minerals reports strong progress on its Browns Range Heavy Rare Earths Project with key regulatory approvals, promising exploration results, and near-completion of its Definitive Feasibility Study amid tightening global supply.